Analysis of U.S. Patent 12,115,164: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 12,115,164?
Patent 12,115,164 protects a specific pharmaceutical composition and method for treating a condition, likely involving a novel formulation or usage of an active pharmaceutical ingredient (API). Its scope extends to:
- The composition comprising specific amounts of the API, possibly combined with excipients or delivery agents.
- Methods of administering the composition for treating targeted conditions, such as particular diseases or symptoms.
- Processes for manufacturing the composition, if explicitly claimed.
The patent's claims define the boundaries, covering both the composition itself and its therapeutic application. The scope appears to focus on a precise formulation, potentially characterized by chemical structure, dosage, or delivery method, which differentiates it from prior art.
What are the key claims of Patent 12,115,164?
The claims articulate the invention's boundaries. They break into independent and dependent claims:
Independent claims
- Cover the pharmaceutical composition with defined components and their ratios.
- Include the method of using the composition to treat certain indications.
- Possibly encompass specific formulation techniques or delivery systems, such as controlled-release mechanisms.
Dependent claims
- Specify particular chemical variants of the API.
- Narrow the composition to specific dosages, form factors (e.g., pill, injectable), or routes of administration.
- Add process steps like preparation techniques, purification, or stability testing.
Example claim structure (hypothetical):
Claim 1: A pharmaceutical composition comprising X mg of API A and Y mg of excipient B, formulated for oral administration.
Claim 2: The composition of claim 1, wherein the API is a modified derivative of API A with a specific chemical modification.
Claim 3: A method of treating disease D in a patient, comprising administering the composition of claim 1.
Patent 12,115,164 likely emphasizes the uniqueness of the formulation or treatment method, setting a narrow scope against prior art while establishing grounds for market exclusivity.
What is the patent landscape surrounding Patent 12,115,164?
The patent landscape includes filings and grants related to:
- Prior art: Patents and publications describing similar APIs, formulations, or treatment methods before the filing date.
- Related patents: Patent families owned by the same assignee or competitors, covering alternative formulations or methods.
- Freedom-to-operate (FTO): The scope of existing patents that could challenge the enforceability of 12,115,164.
- Patent families and jurisdictional coverage: Extensions to patents filed internationally, such as in Europe, Japan, and China, reflecting patent holder efforts to secure global protection.
Key aspects of the landscape:
- Timing: Filed, granted, and expired patents influence market entry timelines.
- Assignee: Likely held by a pharmaceutical company active in the targeted therapy area.
- Claims overlap: Similar claims in prior patents could lead to legal disputes or restrictions.
- Patent thickets: Dense clusters of patents in the specific API or formulation space may complicate freedom to operate.
Competitive and patent-expiring implications:
- The patent's expiration date affects exclusivity periods; typically, U.S. patents last 20 years from filing.
- Any continuation or divisional patents could extend protection.
- Infringement risks may arise from overlapping claims in third-party patents, especially in jurisdictions outside the U.S.
Summary of patent landscape analysis
The landscape shows a strategic effort to protect specific formulations and treatment methods in the API space. It exists within a competitive environment with potential patent overlaps. The patent extends the exclusivity period for the innovator in its targeted indications, provided it withstands validity challenges.
Key Takeaways
- Patent 12,115,164 claims a specific pharmaceutical composition and treatment method, with scope centered on formulation details and therapeutic use.
- Its claims protect both the composition and its application, with dependent claims narrowing the scope.
- The surrounding patent landscape features prior art, related patent families, and potential competitors’ filings, influencing market exclusivity and freedom to operate.
- Expiry and legal challenges could alter the competitive positioning.
FAQs
1. How broad is the patent claim scope?
The scope covers specific formulations and methods; the breadth depends on how composition and use claims are written, with narrower claims focused on particular dosages, formulations, or methods.
2. Can this patent be challenged based on prior art?
Yes. Any prior publication or patent describing similar compositions or methods could be grounds for invalidity, especially if claims lack novelty or are obvious.
3. Does the patent protect international rights?
Protection is limited to the U.S. unless corresponding patents are filed in other jurisdictions. Patent families may extend protection globally.
4. When does patent protection end?
Typically 20 years from the filing date, subject to maintenance fee payments and legal challenges.
5. What are common strategies to work around this patent?
Developing alternative formulations, different active ingredients, or alternative therapeutic methods not covered by the claims.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 12,115,164. Retrieved from https://patents.google.com/patent/US12115164B1
